CDK5R1
CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1, also known as p35, p35nck5a or Nck5a) encodes p35, a neuron-specific activator of cyclin-dependent kinase 5 (CDK5). The p35/CDK5 complex supports central nervous system development, neurite outgrowth and cortical lamination. Browse Assay Genie's current range of CDK5R1 research reagents below, or read on for the biology behind the target.
CDK5R1 encodes p35, a neuron-specific activator of CDK5. CDK5 activation by p35 is required for proper development of the central nervous system, and the p35/CDK5 complex is needed for neurite outgrowth and cortical lamination. The complex also contributes to dendritic spine morphogenesis by mediating EFNA1-EPHA4 signalling, and p35 is described as an activator of TPKII.
The p35/CDK5 complex also takes part in regulating the circadian clock. It modulates the function of the CLOCK protein by phosphorylating it at Thr-451 and Thr-461, which regulates the transcriptional activity of the CLOCK-BMAL1 heterodimer and is associated with altered stability and subcellular distribution. UniProt places the protein at the cell membrane, in neuron projections, in the perikaryon, in the perinuclear cytoplasm and in the nucleus. It belongs to the cyclin-dependent kinase 5 activator family, and the mouse and rat orthologues are both named Cdk5r1.
p35 is proteolytically cleaved by calpain to produce a p25 form. This cleavage relocalises the protein from the cell periphery to nuclear and perinuclear regions. P25 deregulates CDK5 by prolonging its activation and changing where it acts. The p25 form accumulates in the brain neurons of patients with Alzheimer's disease, which correlates with increased CDK5 kinase activity and may lead to aberrantly phosphorylated tau, a microtubule-associated protein that contributes to the disease. This makes the CDK5R1 gene and its protein products a frequent subject in neurodegeneration research. The previous HGNC name was cyclin-dependent kinase 5, regulatory subunit 1 (p35).
p35 activation of CDK5 is required for proper central nervous system development, including neurite outgrowth and cortical lamination.
Calpain cleavage of p35 to p25 deregulates CDK5, and p25 accumulates in the brain neurons of Alzheimer's disease patients.
The p35/CDK5 complex mediates EFNA1-EPHA4 signalling in dendritic spine morphogenesis.
p35/CDK5 phosphorylates CLOCK at Thr-451 and Thr-461, modulating CLOCK-BMAL1 transcriptional activity, stability and subcellular distribution.
CDK5R1 encodes p35, a neuron-specific activator of CDK5. The p35/CDK5 complex is required for neurite outgrowth, cortical lamination and dendritic spine morphogenesis, and it phosphorylates CLOCK to regulate the CLOCK-BMAL1 heterodimer in the circadian clock.
CDK5R1 is also known as p35, p35nck5a and Nck5a, and its UniProt name is cyclin-dependent kinase 5 activator 1. Calpain cleaves p35 to give p25, which relocalises to nuclear and perinuclear regions and prolongs CDK5 activation.
The p25 fragment of CDK5R1 accumulates in the brain neurons of patients with Alzheimer's disease. This correlates with raised CDK5 kinase activity and may lead to aberrantly phosphorylated tau. Mouse and rat carry the orthologue Cdk5r1; check the datasheet of any product for its validated reactivity.
CDK5 and other cyclin-dependent kinases, CDK5-associated proteins and CDK inhibitors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15078; product specifications from Assay Genie datasheets.